Capital International Investors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $788M | Buy |
+21,880,620
| New | +$788M | 0.14% | 132 |
|
|
2023
Q2 | – | Sell |
-3,831,349
| Closed | -$138M | – | 446 |
|
|
2023
Q1 | $138M | Buy |
3,831,349
+189
| +0% | +$6.81K | 0.04% | 262 |
|
|
2022
Q4 | $151M | Sell |
3,831,160
-1,167,182
| -23% | -$46.1M | 0.04% | 260 |
|
|
2022
Q3 | $201M | Buy |
4,998,342
+3,735
| +0.1% | +$150K | 0.06% | 239 |
|
|
2022
Q2 | $210M | Buy |
4,994,607
+1,017
| +0% | +$42.8K | 0.06% | 242 |
|
|
2022
Q1 | $195M | Buy |
4,993,590
+4,798
| +0.1% | +$187K | 0.04% | 256 |
|
|
2021
Q4 | $199M | Buy |
4,988,792
+1,325
| +0% | +$52.8K | 0.04% | 269 |
|
|
2021
Q3 | $180M | Sell |
4,987,467
-11,955,241
| -71% | -$432M | 0.04% | 259 |
|
|
2021
Q2 | $694M | Buy |
16,942,708
+493,607
| +3% | +$20.2M | 0.16% | 140 |
|
|
2021
Q1 | $718M | Sell |
16,449,101
-2,252
| -0% | -$98.2K | 0.18% | 128 |
|
|
2020
Q4 | $823M | Buy |
16,451,353
+6,077,310
| +59% | +$304M | 0.22% | 118 |
|
|
2020
Q3 | $436M | Buy |
10,374,043
+2,236,988
| +27% | +$94.1M | 0.13% | 147 |
|
|
2020
Q2 | $395M | Buy |
+8,137,055
| New | +$395M | 0.13% | 143 |
|